Business improvements on track
Revenue down 1.4% (CER) and EBIT margin at 15.1% (CER) for the first 6 months
Revenue growth in Q1; profit affected by exceptional expenses
Nobel Biocare Holding AG’s Annual General Meeting today endorsed all proposals put forward by the Board of Directors.
Operational milestones achieved; financial performance behind
Nobel Biocare Management AG P.O. Box CH - 8058 Zurich-Airport Switzerland
+41 43 211 42 30
+41 79 430 81 46
+41 43 211 42 42
